| P50 | author | Keith Channon | Q56420294 |
| | Eileen McNeill | Q41774481 |
| P2093 | author name string | Jyoti Patel | |
| P2860 | cites work | Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice | Q61386204 |
| | A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q72415283 |
| | ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 |
| | Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 |
| | Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4 | Q75411029 |
| | Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 |
| | Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | Q77340592 |
| | Mouse models of atherosclerosis | Q77555168 |
| | Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway | Q80111777 |
| | Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque | Q80509039 |
| | G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis | Q81546558 |
| | Novel candidate genes in unstable areas of human atherosclerotic plaques. | Q51585538 |
| | Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. | Q51822453 |
| | The specific role of chemokines in atherosclerosis. | Q53555491 |
| | Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. | Q54240315 |
| | Role of inflammation and metalloproteinases in plaque disruption and thrombosis | Q57133777 |
| | Association of intima-media thickening of carotid artery with genetic polymorphisms of the regulator of G-protein signaling 2 gene in patients with hypertension and in the general population | Q58363290 |
| | An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion | Q24300694 |
| | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Regulation of atherogenesis by chemokines and chemokine receptors | Q27003124 |
| | GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins | Q28145018 |
| | The regulator of G protein signaling family | Q28145604 |
| | Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications | Q28275259 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 |
| | Chemokines: a new classification system and their role in immunity | Q29615663 |
| | The many roles of chemokines and chemokine receptors in inflammation | Q29618880 |
| | Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling | Q30014843 |
| | Mammalian RGS proteins: multifunctional regulators of cellular signalling. | Q30354302 |
| | Polarization of chemoattractant receptor signaling during neutrophil chemotaxis | Q30493167 |
| | Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice | Q33236495 |
| | Statins stimulate RGS-regulated ERK 1/2 activation in human calcified and stenotic aortic valves | Q33356824 |
| | Macrophage plasticity in experimental atherosclerosis | Q33527405 |
| | Structure, function, and inhibition of chemokines | Q34110896 |
| | Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. | Q34144328 |
| | The germinal center reaction | Q34148104 |
| | Eukaryotic chemotaxis: distinctions between directional sensing and polarization | Q34188022 |
| | Regulator of G protein signaling proteins: novel multifunctional drug targets | Q34253413 |
| | Current status of chemokine receptor inhibitors in development | Q34304366 |
| | Chemokines in pathology and medicine | Q34328278 |
| | G-protein-coupled receptor dimerization: modulation of receptor function. | Q34578524 |
| | Agonist-selective mechanisms of GPCR desensitization | Q34722029 |
| | Signal transduction and endocytosis: close encounters of many kinds | Q34770359 |
| | A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. | Q40467498 |
| | Structure-activity relationships of chemokines | Q40531026 |
| | Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. | Q40571692 |
| | Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation | Q40699131 |
| | CC chemokine receptor-3 undergoes prolonged ligand-induced internalization | Q40959278 |
| | MIP-3alpha, MIP-3beta and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells | Q40979548 |
| | Differential regulation of G-protein-mediated signaling by chemokine receptors | Q41168752 |
| | Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity | Q41270179 |
| | Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins | Q41700415 |
| | G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors. | Q41982556 |
| | Regulators of G-protein signaling (RGS) 1 and 16 are induced in response to bacterial lipopolysaccharide and stimulate c-fos promoter expression | Q42473246 |
| | Chemokine receptor dimerization: two are better than one. | Q43792050 |
| | Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis | Q44072394 |
| | Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis | Q44342246 |
| | Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6. | Q44666534 |
| | Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells | Q44823348 |
| | Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 |
| | GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo. | Q47286150 |
| | Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. | Q47334929 |
| | Identification of new genes differentially expressed in coronary artery disease by expression profiling | Q47709919 |
| | Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system | Q49071913 |
| | CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. | Q34774168 |
| | Leukocyte extravasation: chemokine transport and presentation by the endothelium | Q34998445 |
| | Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential | Q35195555 |
| | Beta-arrestin-2 regulates the development of allergic asthma | Q35242857 |
| | Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction | Q35523846 |
| | Matrix metalloproteinases A review of their structure and role in acute coronary syndrome | Q35557333 |
| | Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators | Q35578683 |
| | G protein-coupled receptor kinases: more than just kinases and not only for GPCRs | Q35621624 |
| | Chemokines: multiple levels of leukocyte migration control. | Q35753105 |
| | Regulation of chemokine-induced lymphocyte migration by RGS proteins | Q35864175 |
| | WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. | Q36079791 |
| | Dimerization of chemokine receptors and its functional consequences | Q36175293 |
| | R4 RGS proteins: regulation of G-protein signaling and beyond | Q36301542 |
| | Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease | Q36313343 |
| | Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice | Q36482911 |
| | Moving toward understanding eukaryotic chemotaxis | Q36492626 |
| | Chemoattractant receptor signaling and the control of lymphocyte migration. | Q36557763 |
| | GRKs and arrestins: regulators of migration and inflammation | Q36582023 |
| | T cells in atherogenesis: for better or for worse? | Q36594608 |
| | Intertwining of thrombosis and inflammation in atherosclerosis | Q36667645 |
| | Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice | Q36732984 |
| | Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis | Q36765864 |
| | G-protein-coupled receptor expression, function, and signaling in macrophages | Q36800734 |
| | Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs | Q36821880 |
| | Chemotaxis, chemokine receptors and human disease. | Q37034783 |
| | Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models | Q37156680 |
| | The role of adaptive T cell immunity in atherosclerosis | Q37339539 |
| | Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration | Q37383096 |
| | Fine-tuning of GPCR activity by receptor-interacting proteins | Q37638132 |
| | Chemokine receptors intracellular trafficking. | Q37745630 |
| | Heterophilic chemokine receptor interactions in chemokine signaling and biology | Q37819146 |
| | Turning off the signal: desensitization of beta-adrenergic receptor function | Q37887325 |
| | CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges | Q38072673 |
| | Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. | Q39938297 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | membrane protein | Q423042 |
| | signal transduction | Q828130 |
| | cell surface receptor | Q2476074 |
| | atherosclerosis | Q12252367 |
| | chemokine receptor family | Q24720618 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 459520 | |
| P577 | publication date | 2013-04-14 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | The downstream regulation of chemokine receptor signalling: implications for atherosclerosis | |
| P478 | volume | 2013 | |